Cargando…

Structural insights into Resveratrol’s antagonist and partial agonist actions on estrogen receptor alpha

BACKGROUND: Resveratrol, a naturally occurring stilbene, has been categorized as a phytoestrogen due to its ability to compete with natural estrogens for binding to estrogen receptor alpha (ERα) and modulate the biological responses exerted by the receptor. Biological effects of resveratrol (RES) on...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chakraborty, Sandipan, Levenson, Anait S, Biswas, Pradip K
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4015837/ https://www.ncbi.nlm.nih.gov/pubmed/24160181 http://dx.doi.org/10.1186/1472-6807-13-27

Ejemplares similares

OR11-01 A New Model for Estrogen Receptor-alpha Antagonist Mechanism of Action
por: Nwachukwu, Jerome C, et al.
Publicado: (2023)

Profiling of the Tox21 10K compound library for agonists and antagonists of the estrogen receptor alpha signaling pathway
por: Huang, Ruili, et al.
Publicado: (2014)

Three-Dimensional Structural Insights Have Revealed the Distinct Binding Interactions of Agonists, Partial Agonists, and Antagonists with the µ Opioid Receptor
por: Li, Zoe, et al.
Publicado: (2023)

Progesterone receptor isoforms, agonists and antagonists differentially reprogram estrogen signaling
por: Singhal, Hari, et al.
Publicado: (2017)

Antidiabetic Actions of an Estrogen Receptor β Selective Agonist
por: Alonso-Magdalena, Paloma, et al.
Publicado: (2013)

Structure-Based Understanding of Binding Affinity and Mode of Estrogen Receptor α Agonists and Antagonists
por: Lee, Sehan, et al.
Publicado: (2017)

Resveratrol and pterostilbene epigenetically restore PTEN expression by targeting oncomiRs of the miR-17 family in prostate cancer
por: Dhar, Swati, et al.
Publicado: (2015)

Estrogen alpha receptor antagonists for the treatment of breast cancer: a review
por: Sharma, Deepika, et al.
Publicado: (2018)

The structural basis for agonist and partial agonist action on a β(1)-adrenergic receptor
por: Warne, Tony, et al.
Publicado: (2011)

Agonistic and antagonistic estrogens in licorice root (Glycyrrhiza glabra)
por: Simons, Rudy, et al.
Publicado: (2011)

Estrogen Signalling and the Metabolic Syndrome: Targeting the Hepatic Estrogen Receptor Alpha Action
por: Matic, Marko, et al.
Publicado: (2013)

A new class of small molecule estrogen receptor-alpha antagonists that overcome anti-estrogen resistance
por: Ma, Yongxian, et al.
Publicado: (2015)

Competitive molecular docking approach for predicting estrogen receptor subtype α agonists and antagonists
por: Ng, Hui Wen, et al.
Publicado: (2014)

The marionette mechanism of domain–domain communication in the antagonist, agonist, and coactivator responses of the estrogen receptor
por: Chen, Xun, et al.
Publicado: (2023)

Dietary stilbenes as modulators of specific miRNAs in prostate cancer
por: Levenson, Anait S.
Publicado: (2022)

Species‐specific action of (Pro3)GIP – a full agonist at human GIP receptors, but a partial agonist and competitive antagonist at rat and mouse GIP receptors
por: Sparre‐Ulrich, A H, et al.
Publicado: (2015)

Correction: Estrogen Signalling and the Metabolic Syndrome: Targeting the Hepatic Estrogen Receptor Alpha Action
por: Matic, Marko, et al.
Publicado: (2019)

Phytoestrogens are partial estrogen agonists in the adult male mouse.
por: Mäkelä, S, et al.
Publicado: (1995)

Autoantibodies specific to estrogen receptor alpha act as estrogen agonists and their levels correlate with breast cancer cell proliferation
por: Maselli, Angela, et al.
Publicado: (2015)

Targeted DNA oxidation and trajectory of radical DNA using DFT based QM/MM dynamics
por: Biswas, Pradip K, et al.
Publicado: (2019)

Generalized Concentration Addition Predicts Joint Effects of Aryl Hydrocarbon Receptor Agonists with Partial Agonists and Competitive Antagonists
por: Howard, Gregory J., et al.
Publicado: (2010)

Estrogen Mediates an Atherosclerotic-Protective Action via Estrogen Receptor Alpha/SREBP-1 Signaling
por: Xie, Fei, et al.
Publicado: (2022)

Exploring the binding mode and thermodynamics of inverse agonists against estrogen-related receptor alpha
por: Karnati, Konda Reddy, et al.
Publicado: (2020)

Co-expression of estrogen receptor-alpha and targets of estrogen receptor action in proliferating monkey mammary epithelial cells
por: Dimitrakakis, Constantine, et al.
Publicado: (2006)

Muscarinic Receptor Agonists and Antagonists
por: Broadley, Kenneth J., et al.
Publicado: (2001)

Effects of a PPAR -gamma receptor agonist and an angiotensin receptor antagonist on aortic contractile responses to alpha receptor agonists in diabetic and/or hypertensive rats
por: Tugrul, Ibrahim, et al.
Publicado: (2016)

Alpha-peptide receptor radionuclide therapy using actinium-225 labeled somatostatin receptor agonists and antagonists
por: Shi, Mengqi, et al.
Publicado: (2022)

The origins of estrogen receptor alpha-positive and estrogen receptor alpha-negative human breast cancer
por: Allred, D Craig, et al.
Publicado: (2004)

Preliminary Molecular Dynamic Simulations of the Estrogen Receptor Alpha Ligand Binding Domain from Antagonist to Apo
por: McGee, T. Dwight, et al.
Publicado: (2008)

Growth and Bone Mineral Density Changes in Ovariectomized Rats Treated with Estrogen Receptor Alpha or Beta Agonists
por: Kang, Byung Ho, et al.
Publicado: (2020)

Estradiol and Estrogen Receptor Agonists Oppose Oncogenic Actions of Leptin in HepG2 Cells
por: Shen, Minqian, et al.
Publicado: (2016)

In silico selection of an aptamer to estrogen receptor alpha using computational docking employing estrogen response elements as aptamer-alike molecules
por: Ahirwar, Rajesh, et al.
Publicado: (2016)

Transactivation Function-1-Mediated Partial Agonist Activity of Selective Estrogen Receptor Modulator Requires Homo-Dimerization of the Estrogen Receptor α Ligand Binding Domain
por: Arao, Yukitomo, et al.
Publicado: (2019)

Bisphenol AF Is a Full Agonist for the Estrogen Receptor ERα but a Highly Specific Antagonist for ERβ
por: Matsushima, Ayami, et al.
Publicado: (2010)

Estrogen Receptor Alpha as a Key Target of Red Wine Polyphenols Action on the Endothelium
por: Chalopin, Matthieu, et al.
Publicado: (2010)

Cyclopia extracts act as selective estrogen receptor subtype downregulators in estrogen receptor positive breast cancer cell lines: Comparison to standard of care breast cancer endocrine therapies and a selective estrogen receptor agonist and antagonist
por: Olayoku, Folasade R., et al.
Publicado: (2023)

Evidence for biased agonists and antagonists at the endothelin receptors
por: Maguire, Janet J.
Publicado: (2016)

Non-Peptide Agonists and Antagonists of the Prokineticin Receptors
por: Lattanzi, Roberta, et al.
Publicado: (2022)

Hepatocyte estrogen receptor alpha mediates estrogen action to promote reverse cholesterol transport during Western-type diet feeding
por: Zhu, Lin, et al.
Publicado: (2017)

Activity of Estrogen Receptor β Agonists in Therapy-Resistant Estrogen Receptor-Positive Breast Cancer
por: Datta, Jharna, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_r0bdbkqjmh0lm6s5gqdn0kt93r